Potential Adiponectin Receptor Response Modifier Therapeutics

Many human diseases may benefit from adiponectin replacement therapy, but due to pharmacological disadvantages of the intact protein, druggable options focus on peptidic, and small molecule agonists of the adiponectin receptor. Peptide-based adiponectin replacement drug leads are derived from, or re...

Descripción completa

Detalles Bibliográficos
Autor principal: Otvos, Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700268/
https://www.ncbi.nlm.nih.gov/pubmed/31456747
http://dx.doi.org/10.3389/fendo.2019.00539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700268/
https://www.ncbi.nlm.nih.gov/pubmed/31456747
http://dx.doi.org/10.3389/fendo.2019.00539

Ejemplares similares